Market revenue in 2023 | USD 139.0 million |
Market revenue in 2030 | USD 247.4 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceuticals, Devices |
Key market players worldwide | Johnson & Johnson, Cipla Ltd DR, Sun Pharmaceutical Industries, Merck & Co Inc, Dr. Reddy’s Laboratories, Cardiff Lexington Corp, Amgen Inc, Theradome, Aurobindo Pharma, Curallux, Apira Science |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to androgenetic alopecia market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 98.35% in 2023. Horizon Databook has segmented the Japan androgenetic alopecia market based on pharmaceuticals, devices covering the revenue growth of each sub-segment from 2018 to 2030.
Japan has a large geriatric population, which is highly susceptible to hair loss. According to the World Bank, in 2022, around 37.44 individuals belonged to the age group of 65 or above. An increase in R&D on innovative products to address the issue of hair loss is among the key factors contributing to the market growth in Japan.
There is an increase in the ongoing research initiatives in the country for development of novel technologies and products to treat alopecia. For instance, in February 2021, Organ Technologies announced the initiation of preparatory work for launch of a study on development of regenerative medicine for treating alopecia.
Moreover, in October 2022, scientists from Yokohama National University published a study in the journal Science Advances, which stated that they had grown hair follicles in laboratory to manage baldness. Growing interest of key players and research institutes in developing new products & treatments and advances in technologies are expected to drive market growth in Japan.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan androgenetic alopecia market , including forecasts for subscribers. This country databook contains high-level insights into Japan androgenetic alopecia market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account